Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Cash & Equivalents (2016 - 2025)

Hypha Labs filings provide 15 years of Cash & Equivalents readings, the most recent being $38118.0 for Q3 2025.

  • On a quarterly basis, Cash & Equivalents fell 58.19% to $38118.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $38118.0, a 58.19% decrease, with the full-year FY2025 number at $38118.0, down 58.19% from a year prior.
  • Cash & Equivalents hit $38118.0 in Q3 2025 for Hypha Labs, down from $147192.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $1.1 million in Q1 2024 to a low of $21093.0 in Q1 2025.
  • Median Cash & Equivalents over the past 5 years was $115868.0 (2023), compared with a mean of $211581.4.
  • Biggest five-year swings in Cash & Equivalents: surged 817.77% in 2024 and later crashed 98.02% in 2025.
  • Hypha Labs' Cash & Equivalents stood at $90305.0 in 2021, then soared by 72.56% to $155832.0 in 2022, then surged by 97.81% to $308252.0 in 2023, then crashed by 88.13% to $36583.0 in 2024, then grew by 4.2% to $38118.0 in 2025.
  • The last three reported values for Cash & Equivalents were $38118.0 (Q3 2025), $147192.0 (Q2 2025), and $21093.0 (Q1 2025) per Business Quant data.